213 related articles for article (PubMed ID: 18408763)
1. Evidence of functional interaction between NuMA-RARalpha and RXRalpha in an in vivo model of acute promyelocytic leukemia.
Sukhai MA; Thomas M; Xuan Y; Chan LS; Hamadanizadeh SA; Zhang T; Bharadwaj RR; Schuh AC; Wells RA; Kamel-Reid S
Oncogene; 2008 Aug; 27(34):4666-77. PubMed ID: 18408763
[TBL] [Abstract][Full Text] [Related]
2. Modeling acute promyelocytic leukemia in the mouse: new insights in the pathogenesis of human leukemias.
Merghoub T; Gurrieri C; Piazza F; Pandolfi PP
Blood Cells Mol Dis; 2001; 27(1):231-48. PubMed ID: 11358384
[TBL] [Abstract][Full Text] [Related]
3. Essential role for the dimerization domain of NuMA-RARalpha in its oncogenic activities and localization to NuMA sites within the nucleus.
Dong S; Qiu J; Stenoien DL; Brinkley WR; Mancini MA; Tweardy DJ
Oncogene; 2003 Feb; 22(6):858-68. PubMed ID: 12584566
[TBL] [Abstract][Full Text] [Related]
4. In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications.
He LZ; Merghoub T; Pandolfi PP
Oncogene; 1999 Sep; 18(38):5278-92. PubMed ID: 10498880
[TBL] [Abstract][Full Text] [Related]
5. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia.
Rusiniak ME; Yu M; Ross DT; Tolhurst EC; Slack JL
Cancer Res; 2000 Apr; 60(7):1824-9. PubMed ID: 10766166
[TBL] [Abstract][Full Text] [Related]
6. Leukemic transformation by the APL fusion protein PRKAR1A-RAR{alpha} critically depends on recruitment of RXR{alpha}.
Qiu JJ; Lu X; Zeisig BB; Ma Z; Cai X; Chen S; Gronemeyer H; Tweardy DJ; So CW; Dong S
Blood; 2010 Jan; 115(3):643-52. PubMed ID: 19965660
[TBL] [Abstract][Full Text] [Related]
7. Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha.
Cheng GX; Zhu XH; Men XQ; Wang L; Huang QH; Jin XL; Xiong SM; Zhu J; Guo WM; Chen JQ; Xu SF; So E; Chan LC; Waxman S; Zelent A; Chen GQ; Dong S; Liu JX; Chen SJ
Proc Natl Acad Sci U S A; 1999 May; 96(11):6318-23. PubMed ID: 10339585
[TBL] [Abstract][Full Text] [Related]
8. Pro-proliferative function of the long isoform of PML-RARalpha involved in acute promyelocytic leukemia.
Tussié-Luna MI; Rozo L; Roy AL
Oncogene; 2006 Jun; 25(24):3375-86. PubMed ID: 16434964
[TBL] [Abstract][Full Text] [Related]
9. RXRα ligand Z-10 induces PML-RARα cleavage and APL cell apoptosis through disrupting PML-RARα/RXRα complex in a cAMP-independent manner.
Xu L; Zeng Z; Zhang W; Ren G; Ling X; Huang F; Xie P; Su Y; Zhang XK; Zhou H
Oncotarget; 2017 Feb; 8(7):12311-12322. PubMed ID: 28129653
[TBL] [Abstract][Full Text] [Related]
10. Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways.
Dong S; Tweardy DJ
Blood; 2002 Apr; 99(8):2637-46. PubMed ID: 11929748
[TBL] [Abstract][Full Text] [Related]
11. MEK inhibition induces caspases activation, differentiation blockade and PML/RARalpha degradation in acute promyelocytic leukaemia.
Barbarroja N; Siendones E; Torres LA; Luque MJ; Martinez JM; Dorado G; Velasco F; Torres A; López-Pedrera C
Br J Haematol; 2008 Jul; 142(1):27-35. PubMed ID: 18445086
[TBL] [Abstract][Full Text] [Related]
12. Myeloid leukemia with promyelocytic features in transgenic mice expressing hCG-NuMA-RARalpha.
Sukhai MA; Wu X; Xuan Y; Zhang T; Reis PP; Dubé K; Rego EM; Bhaumik M; Bailey DJ; Wells RA; Kamel-Reid S; Pandolfi PP
Oncogene; 2004 Jan; 23(3):665-78. PubMed ID: 14737102
[TBL] [Abstract][Full Text] [Related]
13. Alteration in the cellular response to retinoic acid of a human acute promyelocytic leukemia cell line, UF-1, carrying a patient-derived mutant PML-RARalpha chimeric gene.
Sato A; Imaizumi M; Hoshi Y; Rikiishi T; Fujii K; Kizaki M; Kagechika H; Kakizuka A; Hayashi Y; Iinuma K
Leuk Res; 2004 Sep; 28(9):959-67. PubMed ID: 15234573
[TBL] [Abstract][Full Text] [Related]
14. The integrity of the charged pocket in the BTB/POZ domain is essential for the phenotype induced by the leukemia-associated t(11;17) fusion protein PLZF/RARalpha.
Puccetti E; Zheng X; Brambilla D; Seshire A; Beissert T; Boehrer S; Nürnberger H; Hoelzer D; Ottmann OG; Nervi C; Ruthardt M
Cancer Res; 2005 Jul; 65(14):6080-8. PubMed ID: 16024608
[TBL] [Abstract][Full Text] [Related]
15. PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model.
Kelly LM; Kutok JL; Williams IR; Boulton CL; Amaral SM; Curley DP; Ley TJ; Gilliland DG
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8283-8. PubMed ID: 12060771
[TBL] [Abstract][Full Text] [Related]
16. The theory of APL.
Piazza F; Gurrieri C; Pandolfi PP
Oncogene; 2001 Oct; 20(49):7216-22. PubMed ID: 11704849
[TBL] [Abstract][Full Text] [Related]
17. Correlation among nuclear localization of NuMA-RARα, deregulation of gene expression and leukemic phenotype of hCG-NuMA-RARα transgenic mice.
Sukhai MA; Thomas M; Hamadanizadeh SA; Xuan Y; Wells RA; Kamel-Reid S
Leuk Res; 2011 May; 35(5):670-6. PubMed ID: 21255834
[TBL] [Abstract][Full Text] [Related]
18. Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice.
Zimonjic DB; Pollock JL; Westervelt P; Popescu NC; Ley TJ
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13306-11. PubMed ID: 11087871
[TBL] [Abstract][Full Text] [Related]
19. Normal hematopoiesis after conditional targeting of RXRalpha in murine hematopoietic stem/progenitor cells.
Ricote M; Snyder CS; Leung HY; Chen J; Chien KR; Glass CK
J Leukoc Biol; 2006 Oct; 80(4):850-61. PubMed ID: 16888087
[TBL] [Abstract][Full Text] [Related]
20. Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation.
Nasr R; Guillemin MC; Ferhi O; Soilihi H; Peres L; Berthier C; Rousselot P; Robledo-Sarmiento M; Lallemand-Breitenbach V; Gourmel B; Vitoux D; Pandolfi PP; Rochette-Egly C; Zhu J; de Thé H
Nat Med; 2008 Dec; 14(12):1333-42. PubMed ID: 19029980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
